Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.11851/8197
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Buruk, Banu | - |
dc.contributor.author | Güner, Müberra Devrim | - |
dc.contributor.author | Ekmekçi, Perihan Elif | - |
dc.contributor.author | Çelebi, Aksuyek Savaş | - |
dc.date.accessioned | 2022-01-15T13:00:35Z | - |
dc.date.available | 2022-01-15T13:00:35Z | - |
dc.date.issued | 2022 | - |
dc.identifier.issn | 1471-8731 | - |
dc.identifier.issn | 1471-8847 | - |
dc.identifier.uri | https://doi.org/10.1111/dewb.12333 | - |
dc.identifier.uri | https://hdl.handle.net/20.500.11851/8197 | - |
dc.description.abstract | Background The coronavirus disease (COVID-19) treatment must be based on scientific methods such as clinical trials. Trials involving human subjects and those requiring a risk-benefit analysis may occasionally face challenges owing to the time limitations in the pandemic. Methodology This study analyses the WHO's International Clinical Trials Registry Platform and , where most COVID-19 clinical trials are registered, according to ethical criteria including study design, conflicts of interest, enrollment of healthcare workers, study locations, site-, design-, and participant-related issues. The discussion is based on three aspects: the quality of the information to be produced, the relevance to significant health problems, and the creation or evaluation of interventions, policies, or practices that promote individual or public health. Results There were significant differences between the two platforms regarding the investigational medicinal product (IMP), the comparator, ethics committee/institutional review board approval, plan to share individual participant data, study phase, site, IMP, and design-related issues. Conflict of interest, sponsor information, and management of vulnerable groups were the main areas wherein both platforms lacked sufficient information. Conclusion With this analysis, we aimed to define a minimum set of ethical criteria for clinical trial platforms to obtain standardization between these two platforms. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wiley | en_US |
dc.relation.ispartof | Developing World Bioethics | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Clinical Trials | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | ethics | en_US |
dc.subject | platform | en_US |
dc.subject | Research | en_US |
dc.subject | Standardization | en_US |
dc.title | Comparison of COVID-19 studies registered in the clinical trial platforms: A research ethics analysis perspective | en_US |
dc.type | Article | en_US |
dc.department | Faculties, School of Medicine, Department of Basic Medical Sciences | en_US |
dc.department | Faculties, School of Medicine, Department of Internal Medical Sciences | en_US |
dc.department | Fakülteler, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü | tr_TR |
dc.department | Fakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | tr_TR |
dc.authorid | Celebi, Aksuyek savas / 0000-0002-3637-0711 | - |
dc.identifier.wos | WOS:000695144800001 | en_US |
dc.identifier.scopus | 2-s2.0-85114727051 | en_US |
dc.institutionauthor | Buruk, Banu | - |
dc.institutionauthor | Ekmekci, Perihan Elif | - |
dc.institutionauthor | Çelebi, Aksüyek Savaş | - |
dc.identifier.pmid | 34515393 | en_US |
dc.identifier.doi | 10.1111/dewb.12333 | - |
dc.authorscopusid | 57216357055 | - |
dc.authorscopusid | 57222958594 | - |
dc.authorscopusid | 36518584100 | - |
dc.authorscopusid | 57243137300 | - |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.identifier.scopusquality | Q1 | - |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.languageiso639-1 | en | - |
item.cerifentitytype | Publications | - |
item.openairetype | Article | - |
item.grantfulltext | none | - |
crisitem.author.dept | 03.14. Department of Internal Medicine | - |
crisitem.author.dept | 03.14. Department of Internal Medicine | - |
crisitem.author.dept | 03.14. Department of Internal Medicine | - |
Appears in Collections: | Dahili Tıp Bilimleri Bölümü / Department of Internal Medical Sciences PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Temel Tıp Bilimleri Bölümü / Department of Basic Medical Sciences WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
CORE Recommender
WEB OF SCIENCETM
Citations
1
checked on Apr 20, 2024
Page view(s)
166
checked on Apr 22, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.